AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 210 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $273,000 | +8.8% | 13,980 | -26.2% | 0.01% | 0.0% |
| Q4 2017 | $251,000 | -47.8% | 18,950 | -27.4% | 0.01% | -44.4% |
| Q3 2017 | $481,000 | -21.0% | 26,084 | +5.0% | 0.02% | -28.0% |
| Q3 2016 | $609,000 | -46.6% | 24,849 | -49.0% | 0.02% | -44.4% |
| Q1 2016 | $1,140,000 | +27.2% | 48,719 | +115.9% | 0.04% | +9.8% |
| Q3 2015 | $896,000 | +284.5% | 22,562 | +567.7% | 0.04% | +412.5% |
| Q2 2015 | $233,000 | – | 3,379 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |